Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
A Study of the Value of Plasma N-terminal proBNP Concentrations for Diagnosing Patent Ductus Arteriosus in Preterm Babies.
Sponsor: Medical Research Council
A observational or N/A phase clinical study on Ductus Arteriosus, Patent, this trial is completed. The trial is conducted by Medical Research Council and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Research Council
- National Health Service, United Kingdom
- St George's, University of London
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.